Puma Biotechnology, Inc. (PBYI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 297.57M |
| Enterprise Value | 296.48M |
| P/E Ratio | 17.03 |
| PEG Ratio | -0.47 |
| Price/Sales Ratio | 1.81 |
| Price/Book Ratio | 2.86 |
| Enterprise/Revenue | 1.65 |
| Enterprise/EBITDA | 10.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.11 |
| Return On Assets | 0.12 |
| Return On Equity | 0.18 |
| Revenue | 228.37M |
| Revenue/Share | 4.49 |
| Gross Profit | 170.21M |
| EBITDA | 53.34M |
| Net Income | 31.11M |
| Diluted EPS | 0.61 |
| Total Cash | 108.5M |
| Total Cash/Share | 2.1 |
| Total Debt | 4.87M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.03 |
| Book Value Per Share | 2.84 |
| 52-Week Change | 62.32 |
| 52-Week High | 11.5 |
| 52-Week Low | 4.76 |
| Moving Average 50 Days | 9.82 |
| Moving Average 200 Days | 8.02 |
| Average Volume | 358,329 |
| Shares Outstanding | 51.7M |
| % Held by Institutions | 76.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |